InClin is a full-service Contract Research Organization (CRO) founded in 1998 with offices in San Mateo, California, and Sydney, Australia. Our mission is to collaborate with forward-thinking biotech and pharmaceutical companies in the development of life-changing therapies with the shared goal of improving patient lives. InClin offers an all-encompassing suite of clinical research services, from Phase 1 through Phase 4, and ensures every trial is executed with precision and integrity. Our attentive and collaborative approach, combined with a breadth of therapeutic expertise from highly experienced clinical trial professionals lead to quality on time results. InClin’s global reach through the management of trusted partners to conduct multinational pivotal registrational trials has resulted in approvals by multiple regulatory authorities.
